Toms Capital Investment Management LP Adagio Therapeutics, Inc. Transaction History
Toms Capital Investment Management LP
- $2.54 Billion
- Q3 2024
A detailed history of Toms Capital Investment Management LP transactions in Adagio Therapeutics, Inc. stock. As of the latest transaction made, Toms Capital Investment Management LP holds 698,500 shares of ADGI stock, worth $2.31 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
698,500Holding current value
$2.31 Million% of portfolio
0.09%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ADGI
# of Institutions
77Shares Held
63.9MCall Options Held
2.3KPut Options Held
2.1K-
Lee Ainslie Maverick Capital LTD | Dallas, Tx11.8MShares$38.9 Million0.81% of portfolio
-
Deep Track Capital, LP Greenwich, CT11MShares$36.3 Million1.34% of portfolio
-
M28 Capital Management LP Stamford, CT9.25MShares$30.6 Million29.1% of portfolio
-
Black Rock Inc. New York, NY4.47MShares$14.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.37MShares$14.5 Million0.0% of portfolio
About Adagio Therapeutics, Inc.
- Ticker ADGI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 108,831,000
- Market Cap $505M
- Description
- Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...